IP Library Granted Patent US 9,451,913
Granted Patent B2
US 9,451,913 · App. 13/609,838 · Granted Sep 27, 2016

Transdermal sampling and analysis device

Inventors: John F. Currie (Bethesda, MD); Joseph A. Marcanio (Greensburg, PA); Joseph J. Vidalis (Bethesda, MD)
Assignee: TOUCHTEK LABS, LLC
A61B5/150022A61B5/1486A61B5/14532A61B5/157A61B5/150076A61B5/15087A61B5/15134A61B5/150358A61B5/150854A61B5/150862A61B5/150946A61B5/150984A61B5/0022A61B5/150122A61B5/150412A61B2562/0295
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,451,913
App. No.
13/609,838
Granted
Sep 27, 2016
Kind
B2
Abstract

Transdermal sampling and analysis device, method and system are provided for non-invasively and transdermally obtaining biological samples from a subject and determining levels of analytes of the obtained biological samples. The transdermal sampling and analysis device, method and system may cause disruption to the skin cells to create capillary-like channels from which biological samples may flow to the transdermal sampling and analysis device. The transdermal sampling and analysis device, method and system may collect the biological samples in a reservoir and transport the biological samples to a sensing chamber. The sensing chamber may contain at least two sensing electrodes coated with a biologically reactive element which reacts with the transported biological sample. The sensing chamber may be configured to mitigate the formation of air bubbles which may impede the transport and distribution of the biological sample across the entirety of the sensing chamber.

Claims (54)

1. A transdermal sampling and analysis device comprising:

a substrate having a first side;

at least one disruptor mounted on the first side of the substrate, wherein the at least one disruptor is configured to generate a localized heat capable of altering the permeability characteristics of a stratum corneum layer of skin of an organism, wherein the localized heat causes capillary-like channels between disrupted cells in the stratum corneum;

a reservoir configured to collect and contain a biological sample that is obtained through the capillary-like channels, wherein the reservoir is substantially circular; and

a sensing chamber connected to the reservoir, wherein an outer edge of the sensing chamber intersects the reservoir at an intersection point comprising a tapered smooth surface, and wherein the sensing chamber comprises:

a plurality of channel supports; and

a plurality of channels formed between the channel supports, wherein an aspect ratio of a height to a width of each of the plurality of channels is approximately 10:1; and

a biological sensing element comprising:

at least two sensing electrodes mounted on the first side of the substrate, wherein the biological sensing element is configured to determine the levels of an analyte in the biological sample, wherein the sensing chamber is configured to contain the biological sample around the at least two sensing electrodes.

2. The transdermal sampling and analysis device of claim 1 , wherein the aspect ratio of the height to the width of each of the plurality of channels is less than 10:1.

3. The transdermal sampling and analysis device of claim 1 , wherein the height of each of the plurality of channels formed between the channel supports is about 250 μm.

4. The transdermal sampling and analysis device of claim 1 , wherein the plurality of channels formed between the channel supports comprises six channels.

5. The transdermal sampling and analysis device of claim 1 , wherein the plurality of channel supports are configured parallel to an axis between a center point of the reservoir and a center point of the sensing chamber.

6. The transdermal sampling and analysis device of claim 5 , wherein each of the plurality of channel supports is tapered with a wide dimension distally located from the reservoir and a narrow dimension proximally located from the reservoir.

7. The transdermal sampling and analysis device of claim 6 , wherein a distance between adjacent channel supports is approximately 30 μm, and wherein a distance between an outer edge of the sensing chamber and an adjacent channel support is approximately 35 μm.

8. The transdermal sampling and analysis device of claim 6 , wherein a distance between adjacent channel supports is approximately 35 μm, and wherein a distance between an outer edge of the sensing chamber and an adjacent channel support is approximately 40 μm.

9. The transdermal sampling and analysis device of claim 1 , wherein the plurality of channel supports are configured perpendicular to an axis between a center point of the reservoir and a center point of the sensing chamber.

10. The transdermal sampling and analysis device of claim 1 , wherein:

each of the plurality of channel supports is tapered with a wide dimension distally located from the reservoir and a narrow dimension proximally located from the reservoir;

a distance between adjacent channel supports at the wide dimension is approximately 23 μm;

a distance between adjacent channel supports at the narrow dimension is approximately 33 μm; and

a distance between an outer edge of the sensing chamber and an adjacent channel support at the intersection point is approximately 38 μm.

11. The transdermal sampling and analysis device of claim 1 , wherein surfaces of at least one of the at least two sensing electrodes are coated with a sensing reagent.

12. The transdermal sampling and analysis device of claim 11 , wherein the sensing reagent comprises a biologically reactive element, an electron mediator, and a polymer.

13. The transdermal sampling and analysis device of claim 12 , wherein the biological sample is interstitial fluid and the biologically reactive element is glucose oxidase.

14. The transdermal sampling and analysis device of claim 1 , wherein the aspect ratio of the height to the width of each of the plurality of channels is approximately 1:1.

15. A transdermal sampling and analysis device comprising:

a substrate having a first side;

at least one disruptor mounted on the first side of the substrate, wherein the at least one disruptor is configured to generate a localized heat capable of altering the permeability characteristics of a stratum corneum layer of skin of an organism, wherein the localized heat causes capillary-like channels between disrupted cells in the stratum corneum;

a reservoir configured to collect and contain a biological sample that is obtained through the capillary-like channels, wherein the reservoir is substantially circular; and

a circular sensing chamber surrounding a periphery of the reservoir, the sensing chamber comprising:

a plurality of channel supports; and

a plurality of channels formed between the channel supports, wherein an aspect ratio of a height to a width of each of the plurality of channels is approximately 3:1; and

a biological sensing element comprising at least two sensing electrodes mounted on the first side of the substrate, wherein the biological sensing element is configured to determine the levels of an analyte in the biological sample, wherein the sensing chamber is configured to contain the biological sample around the at least two sensing electrodes.

16. The transdermal sampling and analysis device of claim 15 , wherein surfaces of at least one of the at least two sensing electrodes are coated with a sensing reagent.

17. The transdermal sampling and analysis device of claim 16 , wherein the biologically reactive element is covered with a barrier layer, wherein the barrier layer prevents interference between the biological sample and the sensing reagent.

18. The transdermal sampling and analysis device of claim 16 , wherein the sensing reagent comprises a biologically reactive element, an electron mediator, and a polymer.

19. The transdermal sampling and analysis device of claim 18 , wherein the biological sample is interstitial fluid, and wherein the biologically reactive element is glucose oxidase.

20. The transdermal sampling and analysis device of claim 15 , wherein the height of each of the plurality of channels formed between the channel supports is about 80 μm.

21. The transdermal sampling and analysis device of claim 15 , wherein the plurality of channels formed between the channel supports comprises twenty four channels.

22. A transdermal sampling and analysis device comprising:

a substrate having a first side;

at least one disruptor mounted on the first side of the substrate, wherein the at least one disruptor is configured to generate a localized heat capable of altering the permeability characteristics of a stratum corneum layer of skin of an organism, wherein the localized heat causes capillary-like channels between disrupted cells in the stratum corneum;

a reservoir configured to collect and contain a biological sample that is obtained through the capillary-like channels, wherein the reservoir is substantially circular; and

a sensing chamber connected to the reservoir, wherein an outer edge of the sensing chamber intersects the reservoir at an intersection point comprising a sharp cornered surface, and wherein the sensing chamber comprises:

a plurality of channel supports; and

a plurality of channels formed between the channel supports, wherein an aspect ratio of a height to a width of each of the plurality of channels is approximately 10:1; and

a biological sensing element comprising:

at least two sensing electrodes mounted on the first side of the substrate, wherein the biological sensing element is configured to determine the levels of an analyte in the biological sample, wherein the sensing chamber is configured to contain the biological sample around the at least two sensing electrodes.

23. The transdermal sampling and analysis device of claim 22 , wherein:

each of the plurality of channel supports is tapered with a wide dimension distally located from the reservoir and a narrow dimension proximally located from the reservoir;

a distance between adjacent channel supports at the wide dimension is approximately 23 μm;

a distance between adjacent channel supports at the narrow dimension is approximately 33 μm; and

a distance between an outer edge of the sensing chamber and an adjacent channel support at the intersection point is approximately 37 μm.

Assignments (7)
CHANGE OF NAME Recorded May 11, 2023
From: CLINITECH, LLC
To: CAMBRIDGE MEDICAL TECHNOLOGIES LLC
Reel/Frame 063610/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2016
From: TOUCHTEK LABS, LLC
To: FLEXIBLE MEDICAL SYSTEMS, LLC
Reel/Frame 040723/0824 →
NUNC PRO TUNC ASSIGNMENT Recorded Dec 13, 2016
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: CLINITECH, LLC
Reel/Frame 040724/0128 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE INFORAMTION PREVIOUSLY RECORDED ON REEL 032717 FRAME 0146. ASSIGNOR(S) HEREBY CONFIRMS THE THE ONLY ASSIGNEE SHOULD BE TOUCHTEK LABS, LLC, 15601 CRABBS BRANCH WAY, DERWOOD, MARYLAND 20855. Recorded Jun 10, 2014
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: TOUCHTEK LABS, LLC
Reel/Frame 033119/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2014
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: TOUCHTEK LABS, LLC
Reel/Frame 032868/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2014
From: FLEXIBLE MEDICAL SYSTEMS LLC
To: MEDINA ISF EQUITY, LLC; FLEXIBLE MEDICAL SYSTEMS LLC; TOUCHTEK LABS, LLC
Reel/Frame 032717/0146 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2012
From: CURRIE, JOHN F; MARCANIO, JOSEPH A; VIDALIS, JOSEPH J
To: FLEXIBLE MEDICAL SYSTEMS LLC
Reel/Frame 028935/0174 →
Continuity (3)
Continuation In Part 13294368 · Nov 11, 2011
Provisional Application 61121982 · Dec 10, 2010
Related Publication 20130123595A1 · May 16, 2013